Pegylated interferon α-2b plus ribavirin for older patients with chronic hepatitis C

AIM: To analyze the efficacy and safety of a combination therapy of pegylated interferon (PEG-IFN) α-2b plus ribavirin (RBV) in older Japanese patients (65 years or older) infected with hepatitis C virus (HCV). METHODS: This multicenter study included 938 patients with HCV genotype 1 who received 1....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Kainuma, Mosaburo, Furusyo, Norihiro, Kajiwara, Eiji, Takahashi, Kazuhiro, Nomura, Hideyuki, Tanabe, Yuichi, Satoh, Takeaki, Maruyama, Toshihiro, Nakamuta, Makoto, Kotoh, Kazuhiro, Azuma, Koichi, Shimono, Junya, Shimoda, Shinji, Hayashi, Jun, Group, The Kyushu University Liver Disease Study
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2010
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2941062/
https://ncbi.nlm.nih.gov/pubmed/20845506
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v16.i35.4400
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars